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ABSTRACT		Human	consumption	of	Aloe	vera	as	a	beverage	has	recently	 increased	 in	popularity.	These	benefits	are	controversial	with	some	sources	pointing	out	that	the	putative	effects	of	aloe	are	unsupported	by	clinical	studies;	it	is	important	that	marketed	products	be	tested	for	toxicities	following	oral	consumption.	Hence	this	study	was	designed	to	evaluate	the	toxicological	effect	of	marketed	aloe	health	drinks.	Thirty	either	sex	Wistar	rats	(200-300gm)	were	enrolled	in	this	study	and	are	divided	into	5	groups.	Group	I	receives	Normal	saline	serves	as	vehicle	control,	Group	II	and	III	receives	Product	A-	Low	dose	(0.5	ml	twice	daily,	p.o)	and	High	dose	(1.0	ml	twice	daily,	p.o)	respectively.	Group	IV	and	V	receives	Product	B-	Low	dose	(0.5	ml	twice	daily,	p.o)	and	High	dose	(1.0	ml	twice	daily,	p.o)	respectively.	Weekly	body	weight	and	daily	feed	intake	were	measured.	On	28th	day	total	urine	output	volume,	faecal	consistency,	Haematological,	biochemical,	and	organ	weight	were	measured	to	assess	the	toxicity	of	aloe	health	drinks.	The	result	of	this	study	shows	that	continuous	usage	of	aloe	health	drinks	showed	milder	weight	reduction,	significant	improvement	in	erythropoiesis	also	it	increases	the	WBC	count	and	increases	the	weight	of	spleen	it	may	confirm	the	im-mune	modulatory	effect	of	aloe	health	drink.	At	the	higher	doses,	it	increased	the	SGOT,	SGPT,	serum	urea	and	creatinine	it	may	lead	to	the	hepatotoxicity	and	nephrotoxicity.	In	gastrointestinal	tract	on	prolonged	uses,	it	produced	few	lesions	and	diarrhoea.	It	might	be	concluded	that	prolonged	consumption	of	unpro-cessed	aloe	health	drink	contains	latex,	an	ingredient	which	has	many	health	risks	associated	with	it.	So	it	can	aggravate	health	problems.	
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INTRODUCTION	Herbal	 medicines	 are	 obtained	 from	 plant	 or	 herb	sources,	but	the	active	ingredients	can	still	be	potent	chemicals.	 Because	 of	 this,	 herbal	 supplements	 can	have	 an	 adverse	 effect	 and	 drug	 interactions,	 even	with	each	other	or	with	food	or	alcohol.	Not	all	of	the	
plants	 reported	 to	 be	 useful	 are	 harmless.	 Herbal	products	 contain	 pharmacologically	 active	 ingredi-ents,	 some	 of	which	 have	 been	 associated	with	 ad-verse	effects	[1].	However,	 available	 herbal	 products	 have	 no	 clear	statement	 of	 content	 or	 medically	 related	 infor-mation	on	the	package	labels,	and	have	not	been	val-idated	or	certified	by	any	recognized	body.	This	con-cerns	consumers	and	medical	practitioners	who	may	unknowingly	 counter-prescribe	 these	 herbal	 prod-ucts.	Herbal	drugs	associated	 toxicity	 can	occur	be-cause	 of	 various	 factors	 viz.	 presence	 of	 contami-nants,	incomplete	processing,	drug-herb	interactions,	coexisting	 diseases,	 direct	 toxicity	 (dose/duration),	improper	 herb	 identification,	 and	 preparation	method[2].		Among	 this	Aloe	vera	 juice	as	a	beverage	of	human	consumption	 has	 recently	 increased	 in	 popularity.	Because	of	its	numerous	pharmacological	properties	like	 skin	 care	 medicine,	 dyspepsia,	 amenorrhea,	burns,	colic,	hyper	adenosis,	hepatopathy,	splenopa-thy,	constipation,	abdominal	tumors,	dropsy	carbun-cles,	sciatica,	lumbago,	flatulence,	anti-inflammatory,	antidiabetic,	and	immunity	enhancement.	Apart	from	that	anticancer,	antibacterial	and	antiviral	properties	
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also	reported	in	aloe	vera	preparations[3].	These	po-tential	properties	are	may	be	due	to	the	presence	of	natural	source	which	has	a	lot	of	nutritional	and	me-dicinal	properties.	The	Aloe	vera	plant	can	be	utilized	in	 three	 basic	 forms:	 Aloe	 gel,	 aloe	 latex,	 and	 the	whole	plant	extract[4].		Aloe	vera	is	known	to	have	75	nutrients	that	are	doc-umented:	20	minerals,	20	amino	acids,	and	12	vita-mins.	Minerals	found	are	calcium,	chromium,	copper,	iron,	 magnesium,	 manganese,	 potassium,	 phospho-rus,	sodium,	zinc,	and	selenium	these	trace	elements	are	essential	for	growth.	Amino	acids	are	the	building	blocks	of	proteins	and	muscle	 tissues.	There	are	12	essential	amino	acids	present	in	Aloe	vera;	they	are	alanine,	arginine,	asparagine,	cysteine,	glutamic	acid,	glycine,	histidine,	proline,	serine,	tyrosine,	glutamine,	and	aspartic	Acid.	Vitamins	are	defined	as	a	group	of	organic	micronutrients	that	are	essential	for	normal	metabolism.	Vitamins	present	 in	Aloe	vera	are	vita-min	A,	B	(Thiamine),	B2	(Riboflavin),	B3	(Niacin),	B5,	B6	 (Pyridoxine),	 B12,	 vitamin	 C,	 E,	 choline	 and	 folic	Acid.	Vitamin	B	complex	and	C	are	considered	to	play	an	 important	 role	 in	 reducing	stress	and	 inflamma-tion.	 Vitamin	 B12	 is	 required	 for	 the	 production	 of	blood	cells.	Enzymes	present	in	Aloe	vera	are	ligase,	amylase,	 catalase,	 bradykinase,	 lipases,	 and	 prote-ases.	Among	these	constituents,	anthraquinones	are	the	most	important	active	ingredient	of	high	medical	values.	The	biological	activities	of	Aloe	vera	are	due	to	 the	synergistic	action	of	a	variety	of	 compounds,	rather	 than	 a	 single	 defined	 compound[5].	 Chronic	abuse	of	anthraquinone	stimulant	laxatives	can	lead	to	hepatitis	and	electrolyte	disturbances	(hypokale-mia,	hypocalcaemia),	metabolic	acidosis,	malabsorp-tion,	 weight	 loss,	 albuminuria,	 and	 haematuria.	Weakness	and	orthostatic	hypotension	may	be	exac-erbated	in	elderly	patients	when	stimulant	laxatives	are	repeatedly	used[6-7].	Applying	aloe	vera	gel	is	considered	safe,	but	consum-ing	 unprocessed	 juice	 extracted	 from	 the	 latex	 can	cause	 several	 side	 effects	 leading	 to	 major	 health	risks.	Like	Aloe	vera	juice	contains	a	substance	called	anthraquinone,	a	laxative,	which	can	cause	diarrhoea	when	 consumed	 in	 large	 amounts.	 Severe	 diarrhea	can	 cause	 pain,	 cramps,	 and	 dehydration.	 So	 this	screening	is	mainly	focused	on	the	subacute	toxicity	of	marketed	aloe	health	drinks	in	Wistar	rats.	
MATERIALS	AND	METHODS	
Drugs	and	Chemicals	The	two	different	manufacturer	marketed	product	of	aloe	health	drinks	were	purchased	and	included	for	toxicological	screening.	These	are	labelled	as	Product	A	and	Product	B.	All	the	chemicals	used	in	this	study	were	of	analytical	grade.		
Selection	of	Animals	The	colony	inbred	adult	both	male	and	female	Albino	Wistar	Rats,	weighing	200-300gm	were	used	in	this	
study.	The	animals	were	kept	under	 standard	envi-ronmental	 conditions	 of	 12/12	 light/dark	 rhythm,	maintained	at	controlled	room	temperature	(23±20C)	and	a	relative	humidity	of	60%±10%,	in	polypropyl-ene	 cages.	 They	were	 fed	with	 standard	 pellet	 diet	and	water	ad	 libitum.	Each	cage	contained	3	rats	of	the	same	sex	with	a	bedding	of	husk.	The	immature	animals	were	 acclimatized	 under	 laboratory	 condi-tions	three	days	prior	to	initiation	of	the	experiment.	The	cages	were	cleaned	daily	by	changing	 the	husk	bedding.	The	experimental	protocol	was	approved	by	the	Institutional	Animal	Ethical	Committee	(IAEC)	of	Swamy	 Vivekanandha	 College	 of	 Pharmacy,	Elayampalayam,	Namakkal-637205,	 care	and	use	of	laboratory	 animals	 were	 confirmed	 to	 CPCSCEA	guidelines	 (Approval	 no:	 IAEC	 Reference	 No:	SVCP/IAEC/UG/1/05/2016).		
Experimental	design	Thirty	Wistar	rats	weighing	200	to	300gm	were	ran-domly	divided	into	five	groups	of	six	per	each.	Group	I,	vehicle	control	receives	normal	saline;	Group	II,	re-ceives	 0.5	ml	 of	 product	A	 at	 low	dose	 twice	 daily;	Group	III,	receives	1ml	of	product	A	at	high	dose	1.0	ml	twice	daily;	Group	IV,	receives	0.5	ml	of	product	B	at	 low	 dose	 twice	 daily,	 Group	 V,	 receives	 1	 ml	 of	product	B	at	high	dose	twice	daily.		
Body	Weight		Body	weight	of	each	rat	in	all	groups	was	measured	weekly	 till	 continuation	 of	 the	 treatment	 using	 a	weighing	balance	and	the	changes	was	recorded.		
Urine	output		Urine	output	volume	was	measured	in	all	 the	treat-ment	on	the	28th	day,	each	animal	was	placed	 in	an	individual	 metabolic	 cage	 24	 hr	 prior	 to	 the	 com-mencement	of	the	study	for	adaptation.	Animals	are	placed	 in	 the	metabolic	 cages,	 specially	designed	 to	separate	urine	and	faeces	and	kept	at	21°C±0.5°C.	The	total	volume	of	urine	collected	for	5	hr	was	measured	at	the	end.	During	this	period	free	assess	of	food	and	water	was	made	available	to	animals[8].		
Examination	of	faecal	consistency		Throughout	the	study	period,	the	faecal	consistency	and	frequency	were	the	monitor.	On	28th	day	after	ad-ministration	of	health	drinks	animals	were	placed	in	cages,	where	the	floor	was	lined	with	non-wetting	pa-per	 sheets	 of	 uniform	 weight.	 Non-wetting	 paper	sheets	were	changed	every	hour	up	to	6	hours.	Char-acteristic	 diarrhoeal	 droppings	 of	 every	 hour	 up	 to	the	6th	hour	were	recorded	after	draining	the	urine	by	gravity[9].		
Haematology	On	the	28th	day	of	the	study,	the	animals	were	anes-thetized	 with	 diethyl	 ether.	 The	 blood	 was	 drawn	through	retro-orbital	plexus	and	collected	 into	Eth-ylene	diamine	tetraacetic	acid	(EDTA)	anticoagulant	
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tubes.	The	blood	was	analyzed	following	haematolog-ical	parameters	which	included	red	blood	cells	(RBC)	count,	white	blood	cells	(WBC)	counts,	haemoglobin	(Hb)	 content,	 and	 packed	 cell	 volume	 (PCV)	 using	standard	 laboratory	 methods	 as	 described	 by	Ghai[10].		
Biochemical	parameters	On	28th	day	biochemical	analyses	were	performed	in	serum	obtained	after	centrifugation	of	blood	without	anticoagulant	at	3000	rpm	for	10	min.	The	analysis	of	serum	glutamate	pyruvate	(SGPT)	and	glutamate	ox-aloacetate	 transaminase	 (SGOT),	 alkaline	 phospha-tase	(ALP)[11],	total	bilirubin,	Urea	and	creatinine[12-
13]	were	estimated	in	serum	by	standard	laboratory	techniques.	
Organ	weight	At	the	end	of	the	study	all	the	animals	were	sacrificed	and	vital	organs	viz.	liver,	kidney,	spleen,	heart,	brain,	uterus,	 and	 testes	 were	 removed	 and	 subjected	 to	gross	examination	and	later	weighed.	Intestinal	tract	was	removed	and	subjected	to	gross	examination.	
Statistical	analysis	The	data	represents	as	mean	±	SEM	of	six	replicated	determinations.	 Results	 were	 analyzed	 statistically	by	 one-way	 ANOVA	 followed	 by	 post	 hoc	 Dunnet’s	test	by	using	SPSS	V.17	 (Student	 trail	 version).	The	difference	was	considered	significant	when	p<0.05.	
RESULTS	AND	DISCUSSION	Aloe	vera	is	a	succulent	cactus	plant,	belonging	to	the	family	 Liliaceae.	 It	 is	widely	 known	 as	 “the	Miracle	plant”	for	its	various	medical,	cosmetic	and	nutraceu-tical	purposes.	Aloe	vera	gel	is	a	slick	substance	that	is	 extracted	 from	 the	 interior	 of	 the	 aloe	 vera	 leaf,	while	 latex	 refers	 to	 the	 yellow	part	which	 lies	 be-neath	the	leaf	skin.	Using	aloe	vera	gel	is	considered	safe,	 but	 consuming	 unprocessed	 juice	 extracted	from	the	latex	can	cause	several	side	effects	leading	to	major	health	risks.	Aloe	vera	juice	contains	a	sub-stance	 called	 anthraquinone,	 a	 laxative,	 which	 can	cause	diarrhea	if	taken	in	large	amounts.	Severe	diar-rhea	can	cause	pain,	cramps,	and	dehydration.	How-ever,	because	of	increased	consumption	of	aloe	vera	drinks,	it	is	important	that	marketed	products	have	to	be	tested	for	toxicities	following	oral	consumption.	In	this	study,	we	have	selected	two	marketed	product	of	Aloe	health	drink	from	two	different	manufactur-ers	 for	 oral	 toxicological	 screening.	 At	 end	 of	 the	study	body	weight	of	Group-II	and	Group-III	(product	A-low	dose	and	high	dose),	Group-V	(product	B-high	dose)	 exhibited	 a	 reduction	 in	 body	 weight	 when	compared	to	the	initial	body	weight.	It	presented	in	
Table 1.	On	long	term	usage	of	aloe	health	drinks	show	slight	weight	 reduction.	 Urine	 output	 volume	was	 signifi-cantly	 (P<0.001)	decreased	 in	 the	Aloe	heath	drink	
treatment	when	compared	to	the	control	group	it	rep-resented	in	Table 2.		It	might	be	due	to	dehydration	because	of	the	laxative	effect	of	 the	anthraquinone	glycoside	content.	 It	 in-creases	intestinal	water	content	by	reducing	the	ab-sorption	of	water	from	intestinal	lumen	by	inhibiting	the	activity	of	Na+,	K+	adenosine	triphosphatase	and	stimulate	water	secretion	by	increasing	the	paracel-lular	permeability	across	the	colonic	mucosa[14].	The	net	result	is	a	reduction	in	water	absorption	and	the	formation	of	softer	stools[15]	and	also	the	loss	of	fecal	consistency	(diarrhoea)	is	may	be	due	to	the	unpro-cessed	 juice	 extracted	 contain	 anthraquinone,	 Aloe	emodin-9-anthrone	 and	 Aloe	 emodin.	 Intestinal	 le-sions	 in	 aloe	health	drink	 fed	 treatment	 group	also	may	 due	 to	 the	 long-term	 consumption	 of	 unpro-cessed	latex	contain	anthraquinone	in	aloe	juice.	Di-arrhoea	was	seen	in	the	treatment	groups	III,	IV,	and	V	when	compared	to	the	vehicle	control	whereas	fae-cal	 consistency	was	 normal.	Milder	 liquefied	 stools	are	seen	in	group	II.	It	was	represented	in	Figure 1.	Aloe	health	 drink	 slightly	 increased	 the	RBC	 count,	WBC	count,	haemoglobin	concentration	and	PCV	was	increased	significantly.	Higher	Hb,	PCV	and	RBC	val-ues	in	the	rats	that	received	the	Aloe	drinks	is	an	in-dication	 that	 it	 stimulated	 erythropoiesis	 in	 those	rats,	 although	 its	potency	 as	 a	haematinic	 is	 low.	 It	presented	in	Table 3.	This	attribute	observed	in	the	Aloe	vera	gel	may	be	due	to	the	presence	of	thiamine,	riboflavin,	folic	acid	and	other	essential	and	non-essential	amino	acids	in	the	mucilaginous	gel[16].	In	this	study,	serum	enzymes	SGOT	 and	 SGPT	 in	 aloe	 health	 drink	 higher	 dose	treated	groups	of	rats	exhibited	a	significant	change	in	comparison	with	control	groups.	Liver	cell	damage	is	characterized	by	rise	in	these	serum	enzymes[17].	It	might	be	due	to	long-term	usage	of	aloe	health	drink	may	lead	to	liver	toxicity.		This	 study	 revealed	 that	 prolonged	 use	 of	 a	 higher	dose	of	aloe	 induces	a	significant	 increase	 in	serum	Urea	and	creatinine.	This	 is	 in	consonance	with	 the	study	of	Avila	et	al[18].	reported	that	the	cytotoxic	ef-fect	of	aloe.	This	 study	suggests	 that	aloe	promotes	nephrotoxicity,	thus	causing	impaired	renal	function	evident	by	an	increase	in	serum	urea	and	creatinine	concentration	Table 4.	The	relative	weight	of	Liver,	heart,	brain,	uterus	and	testes	did	not	show	any	evidence	of	toxicity	and	also	no	significant	changes	in	weight	as	compared	to	con-trol	rats.	Kidney	weight	was	significantly	increased	in	aloe	drink	treatment	which	may	reveals	that	prolong	usage	of	 aloe	health	drink,	may	 lead	 to	nephrotoxi-city.	Spleen	weight	also	shows	increases	it	might	be	due	 to	 the	 immunomodulatory	 effect	 of	 aloe	health	drinks.	Table 5	Table	1-5:	Values	were	expressed	as	mean±SEM,	n=6.	Symbols	 represent	 statistical	 significance:	***p<0.001,	**p	<0.01,	*p<0.05
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Table 1: Changes in body weight 
Treatment	 Initial	body	weight	(g)	 Final	body	weight	(g)	
Group-I	(Vehicle	control)	 251.67±17.01	 258.33±12.49	
Group-II	(Product	A-	Low	dose)	 253.30±12.56	 243.33±4.21	
Group-III	(Product	A-	High	dose)	 253.33±10.85	 238.33±8.33	
Group-IV	(Product	B-	Low	dose)	 248.33±12.22	 261.67±10.14	
Group-V	(Product	B-	High	dose)	 258.33±20.40	 248.40±14.00	
Table 2: Effect of Aloe health drinks on urine output volume 
Treatment	 Total	Urine	Volume	(ml/kg	b.wt./5	h)	
Group-I	(Vehicle	control)		 6.6±0.64	
Group-II	(Product	A-	Low	dose)	 2.0±0.39***	
Group-III	(Product	A-	High	dose)	 1.7±0.30***	
Group-IV	(Product	B-	Low	dose)	 2.9±0.30***	
Group-V	(Product	B-	High	dose)	 1.7±0.48***	
Table 3: Effect of Aloe health drinks on haematological parameters 
Treatment	 RBC	(106/mm3)	 WBC	(103/mm3)	 Hb	(g	%)	 PCV	(%)	
Group-I	(Vehicle	control)	 6.52±0.15	 5.55±0.3	 11.4±0.17	 38.75±1.39	
Group-II	(Product	A	-Low	dose)	 7.01±0.41	 7.31±0.36***	 13.1±0.49***	 41.17±2.38	
Group-III	(Product	A-	High	dose)	 7.82±0.34*	 8.30±0.58***	 14.2±0.32***	 55.35±2.91***	
Group-IV	(Product	B-	Low	dose)	 7.22±0.45	 7.49±0.50***	 12.7±0.43**	 45.25±2.00	
Group-V	(Product	B-	High	dose)	 7.75±0.61*	 9.18±0.36***	 14.5±1.31***	 53.02±2.56***	
Table 4: Effect of Aloe health drinks on Biochemical parameters 
Treatment	 SGOT	(IU/L)	 SGPT	(IU/L)	 ALP	(IU/L)	 Bilirubin	(mg/dl)	 Urea	(mg/dl)	 Creatinine	(mg/dl)	
Group-I	
(Vehicle	
control)	
85.28±3.32	 41.87±2.60	 140.15±12.89	 0.13±0.01	 27.97±1.19	 0.50±0.04	
Group-II	
(Product	A-
Low	dose)	
92.36±2.38	 50.57±1.56	 150.23±10.74	 0.14±0.01	 32.16±2.19	 0.50±0.04	
Group-III	
(Product	A-
High	dose)	
97.88±4.53*	 51.15±3.64*	 147.47±13.49	 0.14±0.01	 47.78±2.14***	 0.71±0.04**	
Group-IV	
(Product	B-
Low	dose)	
92.55±	3.20	 51.97±3.29**	 142.33±13.34	 0.14±0.01	 27.63±1.83	 0.61±0.05	
Group-V	
(Product	B-
High	dose)	
129.35±13.27***	 62.47±4.07***	 150.20±10.89	 0.13±0.01	 48.21±2.79***	 0.73±0.04***	
Table 5: Effect of Aloe health drinks on Organ weight (g/100 gm body weight) 
Treatment	 Liver	(g/100)	 Kidney	(g/100)	 Heart	(g/100)	 Brain	(g/100)	 Spleen	(g/100)	 Uterus	(g/100)	 Testes	(g/100)	
Group-I	
(Vehicle	con-
trol)	
4.31±0.10	 0.77±0.02	 0.31±0.01	 1.08±0.03	 0.22±0.01	 0.50±0.01	 3.00±0.09	
Group-II	
(Product	A-
Low	dose)	
4.34±0.13	 0.82±0.01*	 0.31±0.01	 1.09±0.04	 0.32±0.01***	 0.50±0.01	 3.10±0.11	
Group-III	
(Product	A-
High	dose)	
4.37±0.13	 0.84±0.02	**	 0.31	±0.01	 1.17±0.06	 0.39±0.03***	 0.49±0.01	 3.17±0.08	
Group-IV	
(Product	B-
Low	dose)	
4.40±0.12	 0.82±0.02*	 0.32±0.02	 1.13±0.06	 0.22±0.01	 0.50±0.04	 3.04±0.06	
Group-V	
(Product	B-	
High	dose)	
4.35±0.16	 0.85±0.01***	 0.32±0.02	 1.06±0.04	 0.47±0.03***	 0.48±0.02	 3.07±0.06	
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	CONCLUSION	It	might	be	concluded	that	prolong	consuming	of	un-processed	aloe	health	drink	contains	latex,	an	ingre-dient	which	has	many	health	risks	associated	with	it.	It	can	aggravate	health	problems	like	colitis,	Crohn’s	disease,	 appendicitis,	 diverticulosis,	 intestinal	 ob-struction,	hemorrhoid,	stomach	pains,	and	ulcers.	At	the	higher	doses,	it	increases	the	SGOT,	SGPT,	serum	urea	and	creatinine	it	may	lead	to	the	hepatotoxicity	and	nephrotoxicity.	In	a	gastrointestinal	tract	on	pro-long	uses,	it	produces	few	lesions	and	diarrhoea	also	observed	in	treatments.	So	proper	standardization	of	aloe	 health	 drink	 is	 crucial	 for	 achieve	 its	 putative	benefits	
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Figure 1: Effect of Aloe health drink on faecal consistency-Group-I (vehicle control); Group-II (product A-low 
dose); Group-III (product A-high dose); Group-IV (product B-low dose); Group-V (product B-high dose) 
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